Expression of Bcl-2 or Bcl-xL delays activation of G1 cyclin dependent kinases without altering cyclin D induction.

被引：0
|
作者：
Greider, CA [1 ]
Yang, E [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4457
引用
收藏
页码：173B / 173B
页数：1
相关论文
共 50 条
  • [21] Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
    Punnoose, Elizabeth A.
    Leverson, Joel D.
    Peale, Franklin
    Boghaert, Erwin R.
    Belmont, Lisa D.
    Tan, Nguyen
    Young, Amy
    Mitten, Michael
    Ingalla, Ellen
    Darbonne, Walter C.
    Oleksijew, Anatol
    Tapang, Paul
    Yue, Peng
    Oeh, Jason
    Lee, Leslie
    Maiga, Sophie
    Fairbrother, Wayne J.
    Amiot, Martine
    Souers, Andrew J.
    Sampath, Deepak
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (05) : 1132 - 1144
  • [22] Pyrazole (1, 2-diazole) induce apoptosis in lymphoma cells by targeting BCL-2 and BCL-XL genes and mitigate murine solid tumour development by regulating cyclin-D1 and Ki-67 expression
    Vishnu, Walsan Kalarikkal
    Abeesh, Prathapan
    Guruvayoorappan, Chandrasekharan
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2021, 418
  • [23] High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitors
    Marone, M
    Pierelli, L
    Mozzetti, S
    Masciullo, V
    Bonanno, G
    Morosetti, R
    Rutella, S
    Battaglia, A
    Rumi, C
    Mancuso, S
    Leone, G
    Giordano, A
    Scambia, C
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) : 654 - 662
  • [24] The expression of antiapoptotic proteins Bcl-2, Bcl-XL, and Mcl-1 in benign, dysplastic, and malignant biliary epithelium
    Okaro, AC
    Deery, AR
    Hutchins, RR
    Davidson, BR
    JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (12) : 927 - 932
  • [25] CDK1/CYCLIN B1 MEDIATED BCL-XL/BCL-2 PHOSPHORYLATION PRO-APOPTOTIC SIGNAL FOLLOWING MITOTIC ARREST AND MICROTUBLE INHIBITOR TREATMENT
    Terrano, D.
    Joheim, J. J.
    Sakurikar, N.
    Makhoul, I.
    Hutchins, L. F.
    Chambers, T. C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (04) : 666 - 666
  • [26] 荧光定量PCR技术研究壳寡糖对A549细胞cyclin D1,bcl-xl和bcl-2 mRNA表达的影响
    李贤
    汪炬
    陈小佳
    田金环
    李立华
    赵名艳
    焦延鹏
    周长忍
    科学通报, 2010, (26) : 2587 - 2590
  • [27] Bcl-2 controls caspase activation following a p53-dependent cyclin D1-induced death signal
    Pratt, MAC
    Niu, MY
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) : 14219 - 14229
  • [28] High cyclin dependent kinase inhibitors and p53 levels in Bcl-2 and Bcl-xL-expressing primitive proliferating hematopoietic progenitors
    Marone, M
    Pierelli, L
    Mozzetti, S
    Masciullo, V
    Bonanno, G
    Morosetti, R
    Rutella, S
    Battaglia, A
    Rumi, C
    Mancuso, S
    Leone, G
    Scambia, G
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 108 - 108
  • [29] Diallyl trisulphide-induced apoptosis in human melanoma cells involves downregulation of Bcl-2 and Bcl-xL expression and activation of caspases
    Zhou, C.
    Mao, X. -P.
    Guo, Q.
    Zeng, F. -Q.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (08) : E537 - E543
  • [30] LDL-dependent regulation of Bcl-2 and cyclin 'D' gene expression in lymphocytes from normal and CML patients
    Kaul, D
    Kaur, M
    CANCER LETTERS, 1997, 119 (02) : 131 - 135
12345